Something New

genomeweb
360dx

Something New

Apr 12, 2011

The biopharma industry is facing some tough times, says Forbes' David Shaywitz. Old products' patents are expiring and new products are hard to come by.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Illumina, Chinese Children's Hospital to Launch Newborn Sequencing Study
Cell Microsystems Awarded $1.6M NIH Grant for Single Cell Analysis
RxGenomix, Coriell Life Sciences Form PGx Alliance
Researchers Explore Pathogenic, Drug-Resistant E. coli Population Adaptation Strategies
Prescient Medicine Acquires AutoGenomics
Biocartis, Covance Sign Commercialization Agreement for Idylla

The Scan

Australia's Gene Editing Policy Approach

Australia will not be regulating gene editing of plants, animals, and human cell lines as long as no new genetic material is incorporated, reports Nature News.

Just "Preliminary" Work

The Washington Post reports that the US Department of Agriculture told its researchers to label peer-reviewed articles as "preliminary" work.

Some Big Trees

Researchers have sequenced the genomes of both the coast redwood and the giant sequoia, according to the San Francisco Chronicle.

This Week in PNAS

In PNAS this week: study of epigenetic patterns in mammalian eggs, clonal expansion patterns in CD8+ T cells, and more.

Menu

Something New

To read the full story....

Breaking News

Illumina, Chinese Children's Hospital to Launch Newborn Sequencing Study

Cell Microsystems Awarded $1.6M NIH Grant for Single Cell Analysis

RxGenomix, Coriell Life Sciences Form PGx Alliance

Researchers Explore Pathogenic, Drug-Resistant E. coli Population Adaptation Strategies

Prescient Medicine Acquires AutoGenomics

Biocartis, Covance Sign Commercialization Agreement for Idylla

The Scan

Australia's Gene Editing Policy Approach

Just "Preliminary" Work

Some Big Trees

This Week in PNAS

Sponsorships